Position in INCY
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$1,288,973
+$76,078 QoQ
Shares Held
13,695
+11.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
3 quarters on record
Voting authority
Sole 10.916392844103688.ToString("F0")%
Shared 0.ToString("F0")%
None 89.08360715589632.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TOTH FINANCIAL ADVISORY CORP holds $6,027,293 across 24 Biotechnology names. INCY ranks #1 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
13,695 | $1,288,973 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
6,600 | $1,247,730 | |
| 3 | ASND |
Ascendis Pharma A/S
|
5,450 | $1,246,578 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,000 | $1,046,940 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
10,000 | $869,700 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306 | $136,641 | |
| 7 | ARGX |
Argenx SE
|
145 | $105,886 | |
| 8 | EYPT |
EyePoint, Inc.
|
2,001 | $25,792 |
All Filings in INCY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,288,973 | 13,695 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,212,895 | 12,280 | Shares | Sole | 2026-01-20 | |
| 2020-03-31 | $10,984 | 150 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||